colistimethate sodium
PolandDrugs containing this active substance
-
It is an antibiotic used to treat certain types of severe infections caused by specific bacteria, especially when other antibiotics are not suitable.
Form: powder for preparation of solution for injection / infusion
Active substance Dosage colistimethate sodium 80 mg ATC: J01XB01
Manufacturer: Accord Healthcare Polska Ltd. Laboratori Fundació Dau
-
It is an antibiotic used to treat certain types of severe infections caused by specific bacteria, especially when other antibiotics are not appropriate.
Form: powder for preparation of solution for injection / infusion
Active substance Dosage colistimethate sodium 160 mg ATC: J01XB01
Manufacturer: Accord Healthcare Polska Ltd. Laboratori Fundació Dau
-
The medicine is used to treat chronic respiratory tract infections in patients with cystic fibrosis caused by Pseudomonas aeruginosa bacteria.
Form: powder for preparation of solution for nebulization
Active substance Dosage colistimethate sodium 1000000 j.m. ATC: J01XB01
Manufacturer: Demo S.A.
-
This is an antibiotic used by inhalation (via nebulization) for the treatment of chronic respiratory tract infections in people with cystic fibrosis, caused by Pseudomonas aeruginosa bacteria.
Form: powder for preparation of solution for nebulization
Active substance Dosage colistimethate sodium 2000000 j.m. ATC: J01XB01
Manufacturer: Demo S.A.
-
The medicine is used to treat certain types of severe infections caused by specific bacteria. It is used in situations where other antibiotics are not indicated.
Form: powder for preparation of solution for injection / infusion
Active substance Dosage colistimethate sodium 1000000 j.m. ATC: J01XB01
Manufacturer: Demo S.A.
-
The medicine is used to treat certain types of severe infections caused by specific bacteria, especially when other antibiotics are not indicated.
Form: powder for preparation of solution for injection / infusion
Active substance Dosage colistimethate sodium 2000000 j.m. ATC: J01XB01
Manufacturer: Demo S.A.
-
The medicine is used to treat certain types of severe bacterial infections (administered by injection) and in the treatment of chronic lung infections in patients with cystic fibrosis (administered by inhalation).
Form: solution for injection infusion and inhalation, lyophilisate for preparation of
Active substance Dosage colistimethate sodium 1000000 j.m. ATC: J01XB01
Manufacturer: Lyocontract GmbH Tarchomin Pharmaceutical Works "Polfa" S.A.
-
The medicine is used to treat severe bacterial infections in adults and children. In the case of cystic fibrosis, it is administered via inhalation to treat chronic lung infections caused by Pseudomonas aeruginosa bacteria. It may also be administered into the cerebrospinal fluid for central nervous system infections.
Form: powder for preparation of solution for injection / infusion
Active substance Dosage colistimethate sodium 80 mg ATC: J01XB01
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
The medicine is used to treat certain types of severe bacterial infections in adults and children. In the case of individuals with cystic fibrosis, it is administered via inhalation to treat chronic lung infections caused by Pseudomonas aeruginosa bacteria.
Form: powder for preparation of solution for injection / infusion
Active substance Dosage colistimethate sodium 160 mg ATC: J01XB01
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
The medicine is used to treat certain types of severe infections caused by specific bacteria when other antibiotics are not suitable. In people with cystic fibrosis, it is used via inhalation to treat chronic lung infections caused by the bacterium Pseudomonas aeruginosa.
Form: powder for preparation of solution for injection / infusion
Active substance Dosage colistimethate sodium 240 mg ATC: J01XB01
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.